AplusA Research
AplusA Research is a France-headquartered B2B healthcare market research agency serving pharmaceutical and life sciences clients globally via Custom Research, syndicated Therapy Intelligence™, and Real World Evidence solutions supported by AI/ML analytics across oncology, hematology, immunology, dermocosmetics, and emerging therapies.
- Company typePrivate
- Founded1990
- HeadquartersLyon, France
- Headcount51–100
- GTM typeB2B
- OfferingServices
What AplusA Research does
AplusA Research (legal name APLUSA; brand AplusA Research) is a private, France-headquartered B2B market research agency specialized in the global healthcare industry. The firm is registered in France under number 440 430 569, operates from offices in Boulogne-Billancourt (Paris region), Lyon, London, and New York, and reports a headcount of 51–100 employees. It targets primarily pharmaceutical and life sciences enterprises, with secondary buyers in Medical Affairs and Market Access/HEOR teams within those accounts. The company states 36 years of expertise in generating Real-World Evidence and claims operational reach in 75+ countries via trusted local partners.
The product platform is built around three core solutions: Custom Research (bespoke qualitative and quantitative studies, often multi-year, sometimes pharmacovigilance-bearing), Therapy Intelligence™ (a pre-built, modular syndicated study covering up to 45 countries on an annual subscription that is PV-exempt), and Real World Evidence (data-driven analytics supporting PASS, preference, consensus, and adherence studies). These are wrapped in a Product Lifecycle framework spanning Market Exploration, Value Assessment, and Brand Performance. The analytical stack layers AI/ML sub-products — AI Forecasting (regression, discriminant, random forest), Smart Segmentation (decision trees), and Clustering & Profiling (K-means, Hierarchical Cluster Analysis) — over a proprietary Patient Fitness measurement approach incorporating co-morbidities, age, performance status, quality of life, and functional capacity. Therapeutic coverage spans Solid Tumors, Hematology, Immunology, Dermocosmetics, and Emerging Therapies.
APLUSA's commercial model is consultative enterprise field sales anchored by a Global VP Commercial, a VP Commercial France, a Strategic Partnership Director, and vertical VPs (e.g., Derma-Aesthetic); distribution is direct, with engagement initiated through expert scoping sessions scheduled via HubSpot. Pricing is quote-based and non-public, combining multi-year project pricing (Custom Research and RWE) with an annual shared-cost subscription (Therapy Intelligence™) and data-based pricing for RWE. Revenue, funding history, and ownership structure are not publicly disclosed; no parent company or external investor is identified, implying founder/management-led ownership. Quality credentials include an ISO 2025 certification and a May 2026 EcoVadis Bronze Medal.
AplusA Research firmographics
Firmographics- Name
- AplusA Research
- Legal name
- APLUSA
- Website
- https://aplusaresearch.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- AplusA Research is a France-headquartered B2B healthcare market research agency serving pharmaceutical and life sciences clients globally via Custom Research, syndicated Therapy Intelligence™, and Real World Evidence solutions supported by AI/ML analytics across oncology, hematology, immunology, dermocosmetics, and emerging therapies.
- Ownership category
- akta.pro rank
AplusA Research industry classification
Industry- Product category
- Healthcare Market Research
- NAICS
- Marketing Research and Public Opinion Polling (54191)
- SIC
- Services-Advertising (7310)
- akta.pro primary industry
- Market Research & Consumer Insights (BPAHALAA)
- akta.pro secondary industry
- B2B / Industrial Market Research (MPAAALAA)
Keywords
Where AplusA Research is headquartered
LocationHeadquarters
- HQ city
- Lyon
- HQ country
- France
- HQ region
- Europe
Offices4 records
Markets served
AplusA Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Custom Research Services: Fully tailored bespoke research studies designed around unique client business objectives. Combines qualitative and quantitative approaches with flexible pricing (Custom pricing model). May require pharmacovigilance compliance.
- Therapy Intelligence™: Pre-built syndicated market intelligence solution with modular flexibility. Shared cost model across multiple clients, available in up to 45 countries. PV-exempt, enabling fast access to data without pharmacovigilance obligations.
- Real World Evidence: Custom analytics based on existing real-world data. Supports non-interventional research including PASS, preference, consensus and adherence studies. Data-based pricing structure.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom Research - Bespoke Studies |
| Subscription | Annual | Therapy Intelligence™ - Modular Syndicated Data |
| Usage-based | Multi-year contract | Real World Evidence - Custom Analytics |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
AplusA Research product offering
Product offeringCore offering
AplusA Research is a B2B healthcare market research agency that delivers custom research, syndicated Therapy Intelligence™ modules, and Real-World Evidence analytics to pharmaceutical, biotech, and life sciences clients globally. Its offerings span the full product lifecycle from market exploration through brand performance tracking, leveraging proprietary AI/ML methods such as forecasting, smart segmentation, and clustering. Coverage extends across 75+ countries with a multicultural team of 25+ nationalities.
Product overview
AplusA Research offers a unified healthcare market research platform comprising three core solutions: Custom Research (fully tailored bespoke studies with global reach across 75+ countries), Therapy Intelligence™ (pre-built syndicated insights available in up to 45 countries), and Real World Evidence (patient-centered measurement combining psychosocial science with GPPs). These integrate within a Product Lifecycle framework spanning Market Exploration (early opportunity assessment), Value Assessment (pre-launch strategy), and Brand Performance (post-launch tracking). The offering includes AI-powered analytical tools (AI Forecasting, Smart Segmentation, Clustering & Profiling) applied across five therapeutic areas: Solid Tumors, Hematology, Immunology, Dermocosmetics, and Emerging Therapies.
Differentiator
Problem solved
Functional benefit
Brands
- Therapy Intelligence™: Pre-built syndicated study solution delivering robust multi-country market intelligence data for pharmaceutical companies
- Real World Evidence (RWE)
- Fieldshop
Products and services
- Custom Research Fully tailored bespoke research studies designed around unique business objectives, combining qualitative and quantitative approaches with global reach across 75+ countries and a multicultural team of 25+ nationalities. Targets pharmaceutical and life sciences enterprises needing evidence-based answers to specific strategic questions.
- Therapy Intelligence™ Pre-built syndicated market intelligence solution providing robust multi-country data with fast access, available in up to 45 countries with a flexible modular structure. Shared cost model across multiple clients and PV-exempt, enabling rapid benchmarking for pharmaceutical companies.
- Real World Evidence Real-world data collection and analytics service combining psychosocial science and Good Pharmacoepidemiology Practices (GEPs). Captures insights from physicians, caregivers, and patients through patient chart reviews, longitudinal surveys, and tailored PROMs/PREMs to support non-interventional research including PASS, preference, consensus and adherence studies.
- Market Exploration Early-stage market research offering for pipeline assets that clarifies demand, patient flow, and opportunity size before major investment decisions. Includes market understanding, patient funnel mapping, and opportunity sizing for pharmaceutical clients.
- Value Assessment Pre-launch research studies that quantify true demand and segment physicians and patients to sharpen launch strategy and adoption planning. Includes demand studies, physician segmentation, and patient profiling for pharma and biotech clients.
- Brand Performance In-line brand tracking service that monitors awareness, uptake, messaging impact, and patient experience for post-launch growth optimization. Includes awareness/trial/usage studies, product uptake, sales force effectiveness, and recall testing for pharmaceutical brands.
Quantifiable outcome
- Patient fitness metrics tracked: 63% co-morbidities, 47% age, 57% performance status, 82% quality of life, 73% functional capacity
Companies that use AplusA Research
Customer profileSegments4 records
Ideal customer profiles2 records
AplusA Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
AplusA Research partnerships and signals
Strategic signalScale indicators9 records
Recent moves6 records
Expansion highlights6 records
AplusA Research competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Global leader in life sciences analytics, RWE and market research services; directly comparable to APLUSA on RWE and pharma market intelligence, but operates at vastly larger scale as a broad incumbent.
- Clarivate (DRG / Decision Resources Group): Provider of subscription-based intelligence, market research and RWE for life sciences, including Decision Resources Group; directly comparable in syndicated insights and RWE offerings at much larger scale.
- Ipsos: Large multi-industry market research firm with a dedicated healthcare division; comparable on healthcare market research methodologies, syndicated products and global fieldwork reach.
- Kantar: Global market research powerhouse with healthcare specialty; comparable on syndicated and custom healthcare research across multiple geographies.
- Informa Pharma Intelligence (Citeline): Pharma intelligence and market research provider within Informa; comparable on syndicated insights, R&D pipeline analytics and pharma market intelligence subscription products.
Direct peers
- The Research Partnership: Specialist healthcare and pharma market research firm offering syndicated and custom studies to global pharma clients; directly comparable as a focused mid-market peer in pharma market research.
- Trinity Life Sciences: Strategic advisory and market research firm focused exclusively on the life sciences industry; comparable offering across market research, competitive intelligence and RWE with tech-enabled analytics.
- BioPlan Associates: Specialist market research firm focused on biopharma and biotech manufacturing; comparable as a niche mid-market player in healthcare/biopharma market research with proprietary syndicated data.
- Compas (CMi Group): Specialist healthcare media and market research agency serving pharma clients globally; comparable as a focused healthcare market research peer targeting similar pharmaceutical buyer groups.
Emerging players
- ZoomRx: Tech-forward healthcare market research firm offering AI-driven physician and patient insights; comparable on AI/ML-powered pharma market research and syndicated HCP data products.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
AplusA Research social profiles
Digital presenceAplusA Research compliance and trust
Trust signalCompliance2 records
AplusA Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
AplusA Research leadership team
Management profileNumber of profiles
Profiles9 records
AplusA Research subsidiaries and ownership
Company hierarchySubsidiaries2 records
AplusA Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AplusA Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AplusA Research
What does AplusA Research do?
AplusA Research is a B2B healthcare market research agency that delivers custom research, syndicated Therapy Intelligence™ modules, and Real-World Evidence analytics to pharmaceutical, biotech, and life sciences clients globally. Its offerings span the full product lifecycle from market exploration through brand performance tracking, leveraging proprietary AI/ML methods such as forecasting, smart segmentation, and clustering. Coverage extends across 75+ countries with a multicultural team of 25+ nationalities.
Is AplusA Research a public or private company?
AplusA Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AplusA Research founded?
AplusA Research was founded in 1990. It employs 51 to 100 people.
Where is AplusA Research based?
AplusA Research is headquartered in Lyon, France, in the Europe region.
How does AplusA Research make money?
Three revenue lines are on record. Custom Research Services are the primary driver. The others are therapy Intelligence™ and real World Evidence.
Who are AplusA Research's main competitors?
Broad incumbents on record are IQVIA, Clarivate (DRG / Decision Resources Group), Ipsos, Kantar and Informa Pharma Intelligence (Citeline). Direct peers are The Research Partnership, Trinity Life Sciences, BioPlan Associates and Compas (CMi Group). ZoomRx is listed as an emerging player.
Does AplusA Research have an API?
No public API is recorded for AplusA Research.
What industry is AplusA Research in?
AplusA Research's product category is Healthcare Market Research. Its primary akta.pro industry code is BPAHALAA, Market Research & Consumer Insights, with a secondary code of MPAAALAA, B2B / Industrial Market Research. Its NAICS code is 54191 and its SIC code is 7310.